CY1110345T1 - Χρηση μιας κυτομετρικης αναλυσης ροης για να βελτιστοποιουνται στρατηγικες καταθεσης κυτταρου για cho κυτταρα - Google Patents

Χρηση μιας κυτομετρικης αναλυσης ροης για να βελτιστοποιουνται στρατηγικες καταθεσης κυτταρου για cho κυτταρα

Info

Publication number
CY1110345T1
CY1110345T1 CY20091100905T CY091100905T CY1110345T1 CY 1110345 T1 CY1110345 T1 CY 1110345T1 CY 20091100905 T CY20091100905 T CY 20091100905T CY 091100905 T CY091100905 T CY 091100905T CY 1110345 T1 CY1110345 T1 CY 1110345T1
Authority
CY
Cyprus
Prior art keywords
production
cho cells
cymometric
flow analysis
thaw
Prior art date
Application number
CY20091100905T
Other languages
English (en)
Inventor
Hitto Kaufmann
Juergen Fieder
Ralf Otto
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of CY1110345T1 publication Critical patent/CY1110345T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Abstract

Παρασκευή των βιοφαρμακευτικών από CHO κύτταρα απαιτεί δημιουργία κύριων-, εργασίας- και μετά την παραγωγή τραπεζών κυττάρου υψηλής ποιότητας, μερικώς υπό GMP συνθήκες. Απαιτείται μία βέλτιστη στρατηγική κρυοσυντήρησης για κάθε νέα παραγωγή κυτταρικής γραμμή, ιδιαιτέρως σε σχέση προς τις επιθυμητές για να θεμελιώνονται μέθοδοι παραγωγής που αποφεύγουν πλήρως ορό ή ακόμη οποιαδήποτε ζωικά συστατικά και για να διασφαλίζεται εύρωστη συμπεριφορά επανατήξης για αξιόπιστη παραγωγή. Εδώ περιγράφουμε μία νέα στρατηγική που χρησιμοποιεί κυτομετρική ανάλυση ροής (FC) των κυττάρων που έχουν υποστεί χρώση με Annexin V για υψηλής απόδοσης χαρακτηρισμό των τραπεζών κυττάρου CHO. Τα δεδομένα μας δείχνουν ότι αυτή η μέθοδος επιτρέπει αξιολόγηση μιας μεθόδου κρυοσυντήρησης μόλις 6 ώρες μετά την επανατήξη.
CY20091100905T 2004-11-10 2009-08-28 Χρηση μιας κυτομετρικης αναλυσης ροης για να βελτιστοποιουνται στρατηγικες καταθεσης κυτταρου για cho κυτταρα CY1110345T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04026673 2004-11-10
EP05803011A EP1820022B1 (en) 2004-11-10 2005-11-07 Use of flow-cytometric analysis to optimize cell banking strategies for cho cells

Publications (1)

Publication Number Publication Date
CY1110345T1 true CY1110345T1 (el) 2015-04-29

Family

ID=36118077

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100905T CY1110345T1 (el) 2004-11-10 2009-08-28 Χρηση μιας κυτομετρικης αναλυσης ροης για να βελτιστοποιουνται στρατηγικες καταθεσης κυτταρου για cho κυτταρα

Country Status (15)

Country Link
US (2) US7569339B2 (el)
EP (1) EP1820022B1 (el)
JP (1) JP4620739B2 (el)
KR (1) KR101235658B1 (el)
AT (1) ATE433110T1 (el)
CA (1) CA2578400C (el)
CY (1) CY1110345T1 (el)
DE (1) DE602005014805D1 (el)
DK (1) DK1820022T3 (el)
ES (1) ES2325931T3 (el)
PL (1) PL1820022T3 (el)
PT (1) PT1820022E (el)
SI (1) SI1820022T1 (el)
TW (1) TWI364459B (el)
WO (1) WO2006051065A2 (el)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1820022B1 (en) 2004-11-10 2009-06-03 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flow-cytometric analysis to optimize cell banking strategies for cho cells
CN102369285B (zh) * 2008-11-12 2014-06-18 默沙东公司 用于增强的抗-IGF1R表达的βGl-IgG内含子
JP5775974B2 (ja) 2011-10-28 2015-09-09 プロセナ バイオサイエンシーズ リミテッド アルファシヌクレインを認識するヒト化抗体
WO2013112945A1 (en) 2012-01-27 2013-08-01 Neotope Biosciences Limited Humanized antibodies that recognize alpha-synuclein
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
PE20152004A1 (es) 2013-03-13 2016-02-07 Prothena Biosciences Ltd Inmunoterapia tau
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
WO2015004632A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize iapp
WO2015004633A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize islet-amyloid polypeptide (iapp)
WO2015075635A2 (en) 2013-11-19 2015-05-28 Prothena Biosciences Limited Monitoring immunotherapy of lewy body disease from constipation symptoms
KR20160131082A (ko) 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg1-3에 특이적인 항-라미닌4 항체
CA2938933A1 (en) 2014-03-12 2015-09-17 Prothena Biosciences Limited Anti-laminin4 antibodies specific for lg4-5
TW201623331A (zh) 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子（ｍｃａｍ）抗體類及使用彼等之相關方法
PT3116911T (pt) 2014-03-12 2019-09-04 Prothena Biosciences Ltd Anticorpos anti-mcam e métodos de utilização associados
EP3129051A1 (en) 2014-04-08 2017-02-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
SG11201700097WA (en) * 2014-07-09 2017-02-27 Genentech Inc Ph adjustment to improve thaw recovery of cell banks
TWI769570B (zh) 2015-01-28 2022-07-01 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI718122B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI718121B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
CN104833625B (zh) * 2015-06-04 2018-02-23 武汉友芝友生物制药有限公司 表达重组抗体cho细胞系稳定性的早期鉴定方法
WO2017046776A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017046774A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017149513A1 (en) 2016-03-03 2017-09-08 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2017153953A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
WO2017153955A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
CU24537B1 (es) 2016-05-02 2021-07-02 Prothena Biosciences Ltd Anticuerpos monoclonales que compiten por unirse a tau humano con el anticuerpo 3d6
PE20190208A1 (es) 2016-05-02 2019-02-07 Prothena Biosciences Ltd Anticuerpos que reconocen tau
KR102506091B1 (ko) 2016-05-02 2023-03-07 프로테나 바이오사이언시즈 리미티드 타우 면역요법
WO2017208210A1 (en) 2016-06-03 2017-12-07 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
JP7016470B2 (ja) 2016-07-02 2022-02-07 プロセナ バイオサイエンシーズ リミテッド 抗トランスサイレチン抗体
WO2018007922A2 (en) 2016-07-02 2018-01-11 Prothena Biosciences Limited Anti-transthyretin antibodies
EP3478716A2 (en) 2016-07-02 2019-05-08 Prothena Biosciences Limited Anti-transthyretin antibodies
AU2018263935A1 (en) 2017-05-02 2019-12-19 Prothena Biosciences Limited Antibodies recognizing tau
WO2019064053A1 (en) 2017-09-28 2019-04-04 Prothena Biosciences Limited DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES
KR20210094610A (ko) 2018-11-26 2021-07-29 포티 세븐, 인코포레이티드 c-Kit에 대한 인간화 항체
JP2022524588A (ja) 2019-03-03 2022-05-09 プロセナ バイオサイエンシーズ リミテッド タウ認識抗体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1820022B1 (en) 2004-11-10 2009-06-03 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flow-cytometric analysis to optimize cell banking strategies for cho cells

Also Published As

Publication number Publication date
EP1820022B1 (en) 2009-06-03
JP4620739B2 (ja) 2011-01-26
JP2008518611A (ja) 2008-06-05
PT1820022E (pt) 2009-08-05
WO2006051065A3 (en) 2006-08-03
US20100086947A1 (en) 2010-04-08
US20060121444A1 (en) 2006-06-08
TWI364459B (en) 2012-05-21
DK1820022T3 (da) 2009-09-14
TW200634161A (en) 2006-10-01
CA2578400C (en) 2014-01-14
PL1820022T3 (pl) 2009-11-30
WO2006051065A2 (en) 2006-05-18
EP1820022A2 (en) 2007-08-22
SI1820022T1 (sl) 2009-10-31
ES2325931T3 (es) 2009-09-24
KR101235658B1 (ko) 2013-02-21
DE602005014805D1 (de) 2009-07-16
CA2578400A1 (en) 2006-05-18
KR20070090187A (ko) 2007-09-05
ATE433110T1 (de) 2009-06-15
US7569339B2 (en) 2009-08-04

Similar Documents

Publication Publication Date Title
CY1110345T1 (el) Χρηση μιας κυτομετρικης αναλυσης ροης για να βελτιστοποιουνται στρατηγικες καταθεσης κυτταρου για cho κυτταρα
Forcada et al. Contrasting population changes in sympatric penguin species in association with climate warming
WO2006088867A3 (en) Method for expansion of stem cells
EA201070220A1 (ru) Способ скрининга клеток
ATE541919T1 (de) Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
WO2007041693A3 (en) System and method for array and string level monitoring of a grid-connected photovoltaic power system
WO2010005467A3 (en) Analytical cartridge with fluid flow control
DK1862802T3 (da) Fremgangsmåde til identifikation af med ZAP-70 vekselvirkende molekyler og til rensning af ZAP-70
WO2007035929A3 (en) Method for detecting and quantitating multiple subcellular components
WO2008102602A1 (ja) Ｂｌａｓｔｏｃｙｓｔ ｃｏｍｐｌｅｍｅｎｔａｔｉｏｎを利用した臓器再生法
EA200800769A1 (ru) Перенос клеточных ядер
WO2009016078A3 (en) Method for culturing mammalian stem cells
Montag Morphokinetics and embryo aneuploidy: has time come or not yet?
Lepori et al. A paradox of warming in a deep peri-Alpine lake (Lake Lugano, Switzerland and Italy)
Anderson et al. Integration of multiple components in polystyrene-based microfluidic devices part II: cellular analysis
NO20083274L (no) Fremgangsmate for a vurdere levedyktigheten til tinte celler
FI20060941A (fi) Huokoisen membraanin käyttö kehittyvien havupuun kasvullisten alkioiden tukemiseksi
WO2005052582A3 (en) Methods and apparatus for cell based microarray assays
WO2006125446A3 (en) Quantification of the viability of lactic acid bacteria using flow cytometry
ATE343789T1 (de) Biomolekulares kinetik-messverfahren mit hilfe von einem durchfluss-mikroarray
CN104388535B (zh) 基于贝类耦合生物标志物响应的河口生态需水量估算方法
WO2007063316A3 (en) Method for identifying a modulator of a cell signalling
DE602004025623D1 (de) Kulturemedium für menschlichen Blastozyste
ATE499598T1 (de) Markierungsfreier einzelzelltest
DE602006019628D1 (de) Verfahren zum testen von enzymaktivität in einer histologischen probe